ROLE OF SERUM ONCOSTATIN M IN ASSESSMENT OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE PATIENTS

SERUM VISFATIN LEVEL IN RELATION TO THE SEVERITY OF CORONARY ARTERY DISEASE

Circulating Resistin and Visfatin Levels in Patients with Inflammatory Bowel Disease as Predictors of Treatment Response

Serum Visfatin levels in Ankylosing Spondylitis: Correlation with Disease Activity

Serum Resistin Level as a Novel Marker of Disease Activity in Patients with Ulcerative Colitis

Role of Intestinal Fatty Acid Binding Protein in Treated Inflammatory Bowel Diseases Patients

Serum IL-22 as a Novel Non-Invasive Biomarker in Diagnosis and Assessment of Activity in Ulcerative Colitis Patients

Serum level of Visfatin in Psoriasis and its Relation to Disease Severity

Pentraxin-3: A Novel Specific Biomarker for Inflammatory Bowel Disease Diagnosis

STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE